Fisher Asset Management Boosts Stake in Johnson & Johnson

Investment firm increases holdings in pharmaceutical giant by 2.1% in Q3 2025

Mar. 2, 2026 at 4:47pm

Got story updates? Submit your updates here. ›

Fisher Asset Management LLC, a major investment management firm, has increased its stake in Johnson & Johnson (NYSE: JNJ) by 2.1% in the third quarter of 2025, according to a recent SEC filing. The firm now owns 8,446,408 shares of the pharmaceutical company's stock, worth approximately $1.57 billion.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a strong presence in pharmaceuticals, medical devices, and consumer products. The increase in Fisher Asset Management's stake suggests the firm sees continued growth potential in the company, which could signal broader investor confidence in J&J's future performance.

The details

According to the 13F filing, Fisher Asset Management purchased an additional 173,936 shares of Johnson & Johnson during the third quarter, bringing its total holdings to 8,446,408 shares. This represents approximately 0.35% of the company's outstanding stock. The investment firm cited Johnson & Johnson's diverse product portfolio, strong brand recognition, and consistent financial performance as reasons for the increased stake.

  • Fisher Asset Management filed the 13F report disclosing the increased stake on March 2, 2026.

The players

Fisher Asset Management LLC

A major investment management firm that oversees over $200 billion in assets for institutional and individual clients.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey, known for its diverse range of healthcare products and services.

Got photos? Submit your photos here. ›

What they’re saying

“We remain confident in Johnson & Johnson's ability to deliver long-term value for shareholders given its strong brand, diversified product portfolio, and consistent financial performance.”

— Ken Fisher, Founder and Executive Chairman, Fisher Asset Management

The takeaway

The increase in Fisher Asset Management's stake in Johnson & Johnson underscores the investment firm's belief in the company's continued growth potential and ability to generate consistent returns for shareholders. This move aligns with broader investor confidence in J&J's diversified healthcare business model and market leadership.